HAI Pathogens and Antimicrobial Resistance Report, 2018-2021

Adult Data Tables

Print
PAGE 10 of 19

‹View Table of Contents

Related Pages

Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types1 with High Pathogen Volume, Adults, 2018-2021

Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume, Adults, 2018-2021
Abdominal Orthopedic2 Ob/Gyn3 Cardiac4
Pathogen # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank # Pathogens % Pathogens Rank
Escherichia coli 22,250 19.8 1 2,883 5.2 5 3,555 13.6 1 571 5.4 5
Enterococcus faecalis 10,722 9.5 2 2,851 5.1 6 2,485 9.5 3 322 3.1 9
Bacteroides spp. 8,246 7.3 3 293 0.5 24 1,594 6.1 5 56 0.5 18
Select Klebsiella spp. 7,004 6.2 4 2,083 3.7 8 1,269 4.8 6 709 6.7 4
Candida albicans 6,565 5.8 5 500 0.9 15 275 1.1 18 236 2.2 11
Pseudomonas aeruginosa 6,541 5.8 6 3,702 6.7 3 1,079 4.1 8 913 8.7 3
Staphylococcus aureus 6,407 5.7 7 18,744 33.7 1 3,025 11.6 2 2,574 24.5 1
Enterococcus faecium 5,273 4.7 8 519 0.9 14 165 0.6 24 90 0.9 16
Viridans group streptococci 4,617 4.1 9 611 1.1 12 936 3.6 9 165 1.6 12
Enterobacter spp. 4,433 3.9 10 2,922 5.3 4 824 3.1 10 523 5.0 7
Other Enterococcus spp. 4,115 3.7 11 464 0.8 16 408 1.6 13 49 0.5 22
Coagulase-negative staphylococci 3,318 3.0 12 6,939 12.5 2 1,860 7.1 4 1,389 13.2 2
Citrobacter spp. 2,016 1.8 13 456 0.8 17 334 1.3 14 113 1.1 14
Proteus spp. 1,980 1.8 14 2,350 4.2 7 1,163 4.4 7 434 4.1 8
Candida glabrata 1,893 1.7 15 72 0.1 41 78 0.3 36 55 0.5 19
Other pathogen 16,905 15.1 10,224 18.4 7,131 27.2 2,307 22.0
Total 112,285 100.0 55,613 100.0 26,181 100.0 10,506 100.0

Note: Refer to Technical Resources for more information about the acronyms and terms used in this table.

Footnotes:

  1. The top 4 surgical categories by pathogen volume are shown in this table.
  2. Some rankings are not shown: Serratia spp. (#9, 2.3%); Group B streptococci (#10, 1.9%); Cutibacterium acnes (#11, 1.2%); Morganella spp. (#13, 1.0%).
  3. Some rankings are not shown: Group B streptococci (#11, 3.0%); Prevotella bivia (#12, 2.0%); Morganella (#15, 1.2%).
  4. Some rankings are not shown: Serratia spp. (#6, 5.4%); Cutibacterium acnes (#10, 2.7%); Morganella spp. (#13, 1.6%); Other Candida spp. (#15, 1.0%).

HAI Pathogens and Antimicrobial Resistance Report Data Tables 2018-2021 - Adult HAIs

  1. HAI Pathogens and Antimicrobial Resistance Report 2018-2021 Data Tables - Adult HAIs
  2. Table 1. Facilities Reporting at Least 1 HAI Pathogen to NHSN
  3. Table 2. Frequency of Pathogens and HAI Events Reported to NHSN, by HAI Type
  4. Table 3. The Top 15 HAI Pathogens Reported to NHSN
  5. Table 4. The Top 15 CLABSI Pathogens Reported to NHSN, by Location Type
  6. Table 5. The Top 15 CAUTI Pathogens Reported to NHSN, by Location Type
  7. Table 6. The Top 15 PVAP Pathogens Reported to NHSN, by Facility Type
  8. Table 7. Frequency of SSI Pathogens, by Surgical Category and SSI Type
  9. Table 8. The Top 15 SSI Pathogens Reported to NHSN, by SSI Type
  10. ›Table 9. The Top 15 SSI Pathogens Reported to NHSN Following Surgery Types with High Pathogen Volume
  11. Table 10. The Top 15 SSI Pathogens Reported to NHSN Following Select Surgery Types with Low Pathogen Volume
  12. Table 11. Percent of HAI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats1, by HAI Type
  13. Table 12. Percent of CLABSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  14. Table 13. Percent of CLABSI Pathogens Reported From Oncology Units That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Threats, by Mucosal Barrier Injury (MBI) Status
  15. Table 14. Percent of CAUTI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Location Type
  16. Table 15. Percent of PVAP Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by Facility Type
  17. Table 16. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Surgical Categories with High Pathogen Volume
  18. Table 17. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats for Select Surgical Categories with Low Pathogen Volume
  19. Table 18. Percent of SSI Pathogens That Were Resistant to Selected Antimicrobials and Classified as “Urgent” or “Serious” Antimicrobial Resistant Threats, by SSI Type